Inventor · disambiguated record
Fusheng Zhou
Also filed as: ZHOU FUSHENG
12 granted patents·19 pending applications·12 citations·filing 2015–2023
84Inventor score
Files withGENFLEET THERAPEUTICS SHANGHAI INC18SHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD11GENFLEFT THERAPEUTICS SHANGHAI INC1INSILICO MEDICINE IP LTD1
Top patents by PatentIndex Score
31 records- 0186US12054497B2Substituted heterocyclic fused cyclic compound, preparation method therefor and pharmaceutical use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2020·Granted Aug 6, 2024·3 cites·20 claims
- 0279US10815197B2N-sulfonyl benzamides as voltage-gated sodium channel inhibitorsSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2017·Granted Oct 27, 2020·2 cites·2 claims
- 0378US11155546B24,6,7-trisubstituted 1,2-dihydropyrrolo[3,4-c]pyridin/pyrimidin-3-one derivatives and uses thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2020·Granted Oct 26, 2021·1 cites·19 claims
- 0477US10435400B22,4-disubstituted phenylene-1,5-diamine derivatives and applications thereof, and pharmaceutical compositions and pharmaceutically acceptable compositions prepared therefromSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2015·Granted Oct 8, 2019·3 cites·9 claims
- 0572US10577346B2Benzobicycloalkane derivatives, their preparation and pharmaceutical use thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2017·Granted Mar 3, 2020·1 cites·19 claims
- 0663US12384774B2Polymorph of CDK9 inhibitor and preparation method for polymorph and use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2020·Granted Aug 12, 2025·0 cites·21 claims
- 0763US10227324B22-morpholin-4,6-disubstituted pyrimidine derivative, and preparation method and pharmaceutical use thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2015·Granted Mar 12, 2019·1 cites·24 claims
- 0863US9879008B22,3,4,6-tetra-substituted benzene-1,5-diamine derivatives, preparation method therefor and medicinal use thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2015·Granted Jan 30, 2018·1 cites·10 claims
- 0961US2025145632A1Pyrimidine Heterocyclic Compound, Preparation Method Thereof and use Thereof in MedicineINSILICO MEDICINE IP LTD·Filed 2022·Application pending·0 cites
- 1059US2024352040A1Crystal form of ripk1 inhibitor, acid salt thereof, and crystal form of acid salt thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2022·Application pending·0 cites
- 1158US2025221989A1Pharmaceutical composition, use thereof, and method for treating cancerGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2023·Application pending·0 cites
- 1258US2024158417A1Substituted heterocyclic fused cyclic compound, preparation method therefor and pharmaceutical use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2023·Application pending·0 cites
- 1357US2024294523A1Heterocyclic lactam compound, and preparation method therefor and pharmaceutical use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2022·Application pending·0 cites
- 1456US11174254B2Aniline-substituted 1,2-dihydropyrrol[3,4-C]pyridin/pyrimidin-3-one derivative and use thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2018·Granted Nov 16, 2021·0 cites·12 claims
- 1556US2025051333A1Polymorph of kras inhibitor, preparation method therefor, and use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2022·Application pending·0 cites
- 1655US2024270758A1Pyridino-or pyrimido-cyclic compound, preparation method therefor and medical use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2022·Application pending·0 cites
- 1754US2025084078A1Fused ring-substituted six-membered heterocyclic compound, and preparation method therefor and use thereofGENFLEFT THERAPEUTICS SHANGHAI INC·Filed 2023·Application pending·0 cites
- 1853US2025186456A1Pyrimidine-fused cyclic compound and preparation method and use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2022·Application pending·0 cites
- 1951US2024174691A1Pyrimidine-fused cyclic compound, preparation method therefor and use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2022·Application pending·0 cites
- 2049US2024360154A1Aroyl substituted tricyclic compound, preparation method therefor and use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2021·Application pending·0 cites
- 2149US2024182465A1Fused ring substituted six-membered heterocyclic compound, preparation method therefor and use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2022·Application pending·0 cites
- 2247US2023139111A1Dihydronaphthyridinone compound, and preparation method therefor and medical use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2021·Application pending·0 cites
- 2346US2022363681A1Oxo six-membered cyclopyrimidine compound, preparation method and medical use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2020·Application pending·0 cites
- 2445US2023203060A1Fused tricyclic compound, pharmaceutical composition thereof, and use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2021·Application pending·0 cites
- 2545US2022235032A1Bisheterocyclic carbonyl substituted dihydropyrazole compound, preparation method therefor and pharmaceutical use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2020·Application pending·0 cites
- 2645US2022177462A1Substituted heterocyclic amide compound and preparation method therefor and pharmaceutical use thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2020·Application pending·0 cites
- 2743US2020262813A11,5,7-trisubstituted isoquinoline derivatives, preparation thereof, and use thereof in medicinesSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2017·Application pending·0 cites
- 2842US2022251109A1Oxaazaquinazoline-7(8h)-ketone compound, preparation method therefor and pharmaceutical application thereofGENFLEET THERAPEUTICS SHANGHAI INC·Filed 2020·Application pending·0 cites
- 2935US10793549B2Sulfuryl-substituted benzoheterocyclic derivative, preparation method and medical use thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2017·Granted Oct 6, 2020·0 cites·18 claims
- 3035US10085983B2Azabicyclo derivatives, process for preparation thereof and medical use thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2015·Granted Oct 2, 2018·0 cites·13 claims
- 3133US9890168B22,4-disubstituted 7H-pyrrolo[2,3-d]pyrimidine derivative, preparation method and medicinal use thereofSHANGHAI HAIYAN PHARMACEUTICAL TECH CO LTD·Filed 2015·Granted Feb 13, 2018·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Fusheng Zhou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →